Effects On The Side (Feed Disabled)

In this episode, we delve into the complexities of HPV and take a critical look at Gardasil—the vaccine heralded as a breakthrough against HPV-related diseases. While widely promoted and mandated in many countries, some critics argue that the aggressive push for mass vaccination may have sidelined important discussions about long-term safety, regulatory oversight, and potential conflicts of interest. Join us as we explore both the benefits and the controversies surrounding Gardasil, questioning whether the promise of prevention truly outweighs the concerns raised by its detractors.

Ozempic, the popular diabetes and weight-loss medication, has been making headlines for its ability to help people shed pounds. But behind the hype lies a growing list of disturbing side effects, including reports of brain-related complications and loss of eyesight. In this episode of Effects on the Side, we dig into the latest research, real-life cases, and the scientific mystery behind how a medication designed to regulate blood sugar could be linked to such severe neurological and vision issues. Is Ozempic truly a medical breakthrough, or are we just beginning to uncover its dark side? Tune in as we break it all down.

Have you ever woken up to find out you sent text messages, cooked a meal, or even left your house—all while being asleep? In this episode of Effects on the Side, we uncover the unsettling side effects of Ambien (Zolpidem), one of the most widely used sleep aids in the world. Marketed as a solution for insomnia, Ambien has helped millions get a good night's rest, but at what cost? From sleepwalking to terrifying hallucinations, bizarre behaviors, and even criminal cases linked to its use, we dive deep into the science and real-life consequences of this controversial medication. Join us as we explore the risks, the lawsuits, and whether Ambien is still worth the risk for those struggling with sleep.

This episode traces the history of Vioxx, Merck's promising pain relief drug that became a commercial success in the late 1990s. Following the VIGOR study linking it to cardiovascular risks, Vioxx was recalled in 2004, marking a turning point for drug safety regulations and Merck's reputation. Learn how this pivotal case reshaped the pharmaceutical industry.

Actos promised better glycemic control for patients with Type 2 diabetes but raised serious concerns about risks like bladder cancer and heart failure. This episode examines the benefits, controversies, and the role of patient empowerment in making informed medication choices. Join us as we explore how transparency and active engagement reshape the path for patients and clinicians alike.

Accutane has offered life-changing relief for those struggling with severe acne, but its powerful effects come with equally serious risks. This episode examines its revolutionary results, strict safety measures, and controversies surrounding side effects like depression and IBD. Join us as we weigh the benefits against the drawbacks of this groundbreaking acne treatment.